OEL Fastrac Catalog

Please note, this OEL/ADE monograph also applies to amphetamine sulfate (CAS RN 60-13-9), Amphetamine phosphate (CAS RN 139-10-6), Amphetamine tartrate (CAS RN 13093-77-1), amphetamine aspartate (CAS RN 25333-81-7), Amphetamine adipate (CAS RN 64770-51-0) Amphetamine methanesulfonate (CAS RN 38727-03-6), Amphetamine hydrochloride (CAS RN 2706-50-5), and Amphetamine aspartate monohydrate (CAS RN 851591-76-9). Amphetamine is a central nervous system (CNS) stimulant and a sympathomimetic amine. This agent is a commonly abused psychostimulant drug, which may be snorted, taken orally, smoked, or injected. Amphetamine induces psychologic dependence, which is manifested by elevated mood, increased wakefulness, concentration, physical performance, and a feeling of well-being. With sustained use, the effects of tachycardia and enhanced alertness diminish while psychotoxic effects such as hallucinations and delusions may occur.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Amphetamine, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.